Skip to main content

Table 1 Chronic conditions (CCs), associated medications and ATC codes.

From: Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources

Chronic Disease

Drug Descriptions

ATC Codes

Alzheimer's

Anticholinesterase agents

N06DA; N06DX

 

Digitalis glycosides, antiarrhythmics, diuretics, beta-adrenergic

C01AA; C01BA; C01BB; C01BC; C01BD; C01DA;

Cardiovascular diseases

blockers, alpha blockers, ACE inhibitors, calcium channel

C02AB; C02AC;C02CA; C03AA; C03BA; C03CA;

 

blockers, antihypertensive vasodilators

C03CX; C03DA; C03EA; C03EB; C07AA; C07AB;

Chronic hepatitis

Interferons*

L03AB

Chronic renal disease

Agents for hyperkalaemia and hyperphosphataemia

V03AE; B03XA

Chronic respiratory illnesses

Inhaled corticosteroids, beta-2-adrenoreceptor agonist,

R03AC; R03AK; R03BA; R03BB; R03BC; R03CC;

 

xanthines, leucotriene antagonists, cromolyn

R03DA; R03DC

Cirrhosis

Blood substitutives and plasmatic protein fractions*

B05AA; B02BA

Crohn's and ulcerative colitis

Intestinal corticosteroid agents

A07EA; A07EC

  

A10AB; A10AC; A10AD; A10AE; A10BA; A10BB;

Diabetes

Insulins, biguanides, sulphonylureas

A10BD; A10BG; A10BX

  

N03AA; N03AB; N03AD; N03AE; N03AF; N03AG;

Epilepsy

Anticonvulsivant barbiturates and congeners

N03AX

 

Sympaticomimetic agents*, parasympaticomimetic

 

Glaucoma

agents, anhydrase inhibitors*, ophthalmic beta blockers

S01EA; S01EB; S01EC; S01ED; S01EE; S01EX

HIV/AIDS

Nucleosides and nucleotides*, reverse transcriptase inhibitors

J05AB; J05AD; J05AF

  

A04AA; H01CB; L01AA; L01AB; L01AX; L01BA;

  

L01BB; L01BC; L01DB; L01XB; L01XX; L02AB;

Malignancies

Antineoplastics, 5HT3 antagonists*

L02AE; L02BA; L02BB; L02BG; L03AA; L03AX;

  

R05DA; R05DB27

Migraine

Ergot alkaloids, 5HT1 agonists

N02CA; N02CC; N02CX

Paget's disease/other

 

H05AA02; H05AA03; H05BA; M05BA; M05BB;

osteoporosis chronic

Bisphosphonates*, calcitonin*

G03XC01; M05BX; A12AA; A12AX

conditions

  

Parkinson's

Dopamine, MAO b inhibitors

N04AA; N04AB; N04BA; N04BC; N04BX

Psoriasis

Oral and topical antipsoriasis agents

D05AX; D05BB

  

N05AA; N05AB; N05AC; N05AD; N05AF; N05AG;

Psychiatric disorders

Antidepressants, antipsychotics agents

N05AH; N05AL; N05AN; N05AX; N05BA; N05AA;

  

N06AB; N06AX

  

M01AB; M01AC; M01AE; M01AG; M01AH; M01AX;

Rheumatological conditions

Anti-inflammatory non-steroids*, gold salts, aminoquinolines

M01CB; M01CC; P01BA

Thyroid disorders

Thyroid replacement, antithyroid agents

H03AA; H03BB; H03BC

Tuberculosis

Antituberculosis antibiotics*, isoniazid

J04AB; J04AC; J04AK; J04AM

  1. *drug subject to 'Nota' CUF (see methods section)